Skip to main content
Premium Trial:

Request an Annual Quote

Peakadilly Wins $2.2M from Flanders Government to Develop Protein Biomarker Platform


NEW YORK (GenomeWeb News) – The Flanders government has extended a grant to Peakadilly to speed up development of its biomarker discovery platform, the Belgian company said today.
 
The company plans to use the funds, which total €1.7 million ($2.2 million), to expand relationships with pharma and diagnostic companies and to accelerate development of its own diagnostic products.
 
Peakadilly's biomarker discovery platform is based on its MASStermind techonology, which includes mass spectrometry techniques and data interpretation methods.
 
The Institute for the Promotion of Innovation by Science and Technology in Flanders made the grant extension.
 
In August, Peakadilly raised $10.9 million in venture capital funding.

The Scan

UK Pilot Study Suggests Digital Pathway May Expand BRCA Testing in Breast Cancer

A randomized pilot study in the Journal of Medical Genetics points to similar outcomes for breast cancer patients receiving germline BRCA testing through fully digital or partially digital testing pathways.

Survey Sees Genetic Literacy on the Rise, Though Further Education Needed

Survey participants appear to have higher genetic familiarity, knowledge, and skills compared to 2013, though 'room for improvement' remains, an AJHG paper finds.

Study Reveals Molecular, Clinical Features in Colorectal Cancer Cases Involving Multiple Primary Tumors

Researchers compare mismatch repair, microsatellite instability, and tumor mutation burden patterns in synchronous multiple- or single primary colorectal cancers.

FarGen Phase One Sequences Exomes of Nearly 500 From Faroe Islands

The analysis in the European Journal of Human Genetics finds few rare variants and limited geographic structure among Faroese individuals.